19920409
 Baxter International Slates Human Trials for Blood Substitute   The Wall Street Journal,  Apr 10, 1992  Baxter International Inc will soon begin human trials of a blood substitute derived from donated human blood past its useful shelf life. The company's "Phase I" trials will begin during the summer of 1992. If successful, the substitute could lessen the dependence on donated blood.   
